Skip to main content

Psoriasis, Psoriatic Arthritis Tied to Higher Risk of Polyneuropathy

Medically reviewed by Carmen Pope, BPharm. Last updated on July 29, 2024.

By Lori Solomon HealthDay Reporter

MONDAY, July 29, 2024 -- Psoriasis and psoriatic arthritis may be associated with an increased risk of polyneuropathy, according to a study published online June 28 in Muscle & Nerve.

Pietro E. Doneddu, M.D., from the IRCCS Humanitas Research Hospital in Milan, and colleagues evaluated the risk and features of peripheral neuropathy in patients with psoriasis and psoriatic arthritis. Analysis included 100 consecutive patients with psoriasis or psoriatic arthritis and 100 controls.

The researchers found that nine patients were diagnosed with confirmed polyneuropathy, compared to no controls (relative risk, 19.00). In psoriasis patients, the relative risk for polyneuropathy was 22.09, while those with psoriatic arthritis had a relative risk of 18.75. In the nine patients with polyneuropathy, presentation was length-dependent, symmetrical, and predominantly sensory, with minimal or no disability. Compared to controls, comorbidities and exposure to therapies known to increase the risk of polyneuropathy were more frequent in those with psoriasis or psoriatic arthritis (4 versus 42 percent). When excluding possible contributory causes, risk of polyneuropathy was not significant in patients with psoriasis or psoriatic arthritis.

"This increased risk seems to be linked to the higher prevalence of contributing factors for polyneuropathy, rather than a direct increase in neuropathy risk specifically related to psoriasis and psoriatic arthritis," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted July 2024

Read this next

Flares Occur Frequently in Generalized Pustular Psoriasis

WEDNESDAY, April 16, 2025 -- Patients with generalized pustular psoriasis (GPP) experience frequent flares, and treatment alterations of off-label agents are frequently observed...

Real-World Study Shows Effectiveness of Ixekizumab for Psoriasis

FRIDAY, Feb. 28, 2025 -- For patients with moderate-to-severe plaque psoriasis, ixekizumab is effective and safe, with induction therapy enhancing initial response, according to a...

Childhood Maltreatment May Up Risk for Immune-Mediated Inflammatory Disorders

THURSDAY, Jan. 23, 2025 -- On a global scale, childhood maltreatment is associated with a higher risk for developing some immune-mediated inflammatory disorders (IMIDs), according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.